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Values for experimental permea bility coeffi cients of5-fluo-
rouracil (5-FU) in 7 single- and 4 two-component vehicles 
were determined from flu x measurements through hairless 
m ouse sIGn in diffusion cells and from solubility data. The-
oretical partition coeffi cients o f 5-FU between vehicle and 
skin were determined from solubility parameters of dru g, 
vehicle, and skin , and from this theoreti ca l permea bility 
coeffi cients were estimated . Comparison of theoreti cal w ith 
experimental values for the permeability coeffi cients showed 
a good correlation fo r vehicles w ith solubility parameters 
between 12-18 (ca l /cm3) ~. For vehicles or mixtures o f ve-
I n developing drug preparations for topica l deli very through the skin , the choice of vehicle fo rmulations for a given drug is important to assure adequ ate deli very of the dru g into the skin. The solubility o f a dru g in a chosen vehicle is important in determinin g the rate of deli very into the skin , and this 
solubility is dependent on ph ys icochemi ca l properti es of the dru g 
molecul e and o f the vehicl e. The ability to predi ct percutaneous 
penetra tion of a dru g based on these physicochemi ca l character-
istics would potentiall y enhance topical dru g development by 
decreas ing the need for in vitro and in vivo animal and human 
skin penetration studies . Previously, Sloan and associates [11 pro-
vided the theo retical basis and experimental evidence to show that 
the experim entall y determined perm ea bility coeffi cient (Kp) of a 
dru g in a given vehicle should be directl y proporti onal to the 
produ ct of a theo retica ll y determined partition coeffi cient (PC) 
of the dru g (between skin and vehicle) and a constant (C). The 
theoreti cal equati ons for this rel ati onship are summarized in Table 
I. 
T he ca lculati on of the theo retica l PC of the dru g between ve-
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Abbreviations: 
15: so lubility paramcter 
S- FU : S-flu o rouracil 
Kp: perm eability coefficient 
PC: partition coeffi cient 
hicles with solubility parameters in the range of 8-12 
(cal/cm3) ~, increases in flu x and permeability coeffi cients 
were seen compared with theoretica l predictions, possibly 
due to the similarity in solubility param eters of the vehicles 
to that of skin (1 0 cal/cm3)!. There w as an inverse rela-
tionship between 5-FU solubility in the vehicles and flu x 
or perm eability coeffi cients, with a minimum in flu x and 
permeability coeffi cient that corresponded approximately 
to the point where the solubility parameters o f drug and 
vehicle were the sam e. J bt l/est D enl/atol 89:147-151, 1987 
hick and skin is determined from the ratio of the reciproca l of 
the activity coeffi cient of the drug in the skin to that in the vehicle, 
which in turn depends on the difference between the solubility 
parameter o f the dru g minus that o f the vehicl e squared , and the 
solubility parameter of the drug minus that o f the skin squ ared 
(Eq. 3, T able I). The so lubility parameter (8) is equ al to the square 
root of the cohesive energy (~E) divided by the molar vo lume 
(V). Further, E and V can be es timated by summing the atomic 
and group contribution fo r the energy of va porization and molar 
volume, res pecti vel y [3,4], so that it is possible to ca lculate the 
solubility parameters o f chemica ls that have not been determined 
ex perim entall y. The use o f solubility parameters to predict the 
solubili ty of chemica ls has been useful in a w ide va riety of ap-
plica tions, including the cosmetics industry [5] and the phar-
maceuti ca l industry [6]. 
The anti proliferati ve agent 5-fluorouracil (5-FU) has been ex-
tensively used in topical chem otherapy of cutaneous premali gnant 
and malignant lesions [7]. H yperkerato tic lesions are particularl y 
refracto ry to topica l 5-FU therapy, and lack of penetration of the 
drug thro ugh the thi ckened stratum corn eum is thought to be 
the reason for this inefficacy [8]. T hus, it would be helpful to 
choose a vehicle fo rmulati on for 5-FU that would optimize drug 
delivery in thi s situation. However, so fa r there has not been a 
sys temati c exa mination of vehicles to optimize delivery of 5-FU . 
The current stud y, then, inves ti ga tes the flu x o f 5-FU fr0111 non-
polar to very polar vehicles and the use of the calculated PC 
deri ved from solubility parameters of5-FU and different vehicles 
to attempt to find a vehicle that would maximize delivery of 5-
FU and to see whether the results would be predicted from the 
theo reti ca l relationship outlined in Table I. 
MATERIALS AND METH ODS 
Materials T he 5- FU was obtained fro m Sigma (St. Louis, Mis-
souri ). T he vehicles were obtained from Aldri ch; all were 99% 
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Table I. . Summary of Theoretical Equations Showing the 
Relationship of Permeability Coefficient and Partition 
Coefficient of a Drug in a Vehicle [1] 
Permeability Coefficient (Kp) = Partition Coefficient (PC) x Constant 
(C) 
then log Kp = log PC + log C 
I flu x of drug through skin Wlere Kp = ------=---=---
solubility of drug in vehicle 
(1) 
(2) 
log PC = I(solubility parameter of drug - solubility parameter of vehicle)2 
- (solubility parameter of drug - solubility parameter of skin)2] 
X (molar volume of drug) (volume fraction of vehicle)2/2.3 RT 
or log PC = i(l5i - I5v? - (l5i - 15,)2] Vi<l)2/2 .3 RT (3) 
volume fra ction of vehicle and skin (<1» "" 1 
and 
C = diffusion coefficient of drug = !2 
thickness of sk in h, 
(4) 
<I> = volume fraction; R = 1.98 cal/degree mol; T = 305°K; Solubility parameter 
of skin (6,) = 10 (cal/c l11' )' 121. 
pure and were used as received . The diffusion cells were obtained 
from Kercso Engineering Consultants, Palo Alto , California, and 
were 3 cm in diameter (7.06 cm2 skin surface area) with a 40-ml 
receptor phase volume. A Labline incubator with Variomag stir-
rer was used to maintain constant temperature at 32°C and to stir 
the receptor phases of the cells . Ultraviolet spectril were recorded 
with a Shimadzu UV-160 spectrophotometer. The 18-22 g female 
hairless mice (SKH-hr-l) were obtained from Temple University 
Skin and Cancer Hospital, Philadelphia, Pennsylvania. 
Diffusion Cell Studies The suspensions of 5-FU were stirred 
for 48 h at room temperature before 0.5-ml aliquots were applied 
to the skin. The 5-FU/vehicle suspensions used are summarized 
in Table II; the amount of 5-FU used in each was sufficient to 
assure an excess of 5-FU. 
The mouse skin was prepared and diffusion cell sampling was 
done as previously described [1], with cells run in triplicate for 
each 5-FU/vehicle suspension. Receptor phase samples for UV 
spectrophotometric analysis at 265 nm were generally taken at 0, 
3, 6, 9, 12, 20, 24, 30, 36, and 48 h after the suspensions were 
applied. At the end of this 48 h, the donor phase/skin surface was 
gently washed twice with 10 ml methanol to remove remaining 
5-FU. This methanol wash from each diffusion cell was filtered 
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through Whatman #1 filter paper, and analyzed by UV spec-
troscopy to determine recovery of 5-FU from the donor phase. 
Linear regression analysis of cumulative mg of 5-FU in the 
receptor phase vs time in h gave a slope in mg/h; ill all cases the 
correlation coefficients were at least r = 0.99. Fluxes were ob-
tained by dividing these slopes by the sk in surface area (7.06 cm2), 
and the permeability coefficients (Kp) were then determined by 
dividing the flux (mg/cm2 h) by the corresponding solubility 
of 5-FU (in mg/cm 3 of solution) in that vehicle, as in Eq. 2 of 
Table I. 
Solubility Determinations The solubility of 5- FU in each 
vehicle was determined in triplicate by stirring an excess of 5-FU 
(240 mg 5-FU/3 ml vehicle or mixture of vehicles except for 400 
mg 5-FU/3ml dimethylformamide) in each vehicle in sealed flasks 
for 48 h at room temperature (23 ± 1°C). This time period was 
adequate to insure a saturated solution [9 ,10]. The resulting sus-
pensions were allowed to sit at room temperature for 24 h and 
then were filtered by gravity through Whatman #1 filter paper. 
Aliquots of the filtrates were diluted with methanol for mea-
surement of 5-FU concentration by UV spectroscopy at 265 nm 
(extinction coefficient 5-FU = 7.13 x 103 liters/mol). 
Solubility Parameter and PC Calculations The calculated 
solubility parameters (0;) were obtained usin g the method of Fe-
dors [4], as demonstrated previously [1,11]. For mixed vehicle 
systems, it was assumed that there was no significant change of 
volume on mixing, and OV( I + 2) was calculated as the sum of the 
products of the volume fraction and solubility parameter for each 
vehicle [9]. 
RESULTS 
The vehicles used in the diffusion cell experiments cover a large 
range of solubility parameters; some represent vehicles that could 
be used in therapeutic formulations (e.g., isopropyl myristate, 
propylene glycol). For the diffusiOl'i experiments, saturated so-
lutions of 5-FU were maintained by using suspensions of 5-FU 
in each vehicle. This assumes that dissolution of 5-FU in the 
vehicles did not become the rate-limiting step for diffusion . The 
values for the experimental fluxes, solubility of 5-FU in the ve-
hicles , and experimental permeability coefficient (Kp, calculated 
from Eq. 2 in Table I) are summarized in Table II. The value for 
flux of 5-FU from 5% Efudex (Roche, Nutley , New Jersey) 
solution, which contains propylene glycol, is included for com-
parison. The values for the flux of 5-FU from single vehicles are 
all significantly different from each other at the p < 0.05 level by 
two-sample i-test [12], except for the values of isopropyl myr-
istate vs dimethylformamide. The permeability coefficients of 5-
FU from single vehicles are also significantly different from each 
Table II. Experimental Fluxes, Solubilities, and Permeability Coefficients for the Steady-State Diffusion of 5-Fluorouracil 
Through Hairless Mouse Skin From the Vehicles. 
Flux ± SOl, 
Permeability 
Solubility Coefficient' 
Vehicles" (mg/cm2 h) (mg/cm 3 ) (Kp) 
O leic acid (OA) 0.1 ± 0.012 0.74 0.15 ± 0.016 
Isopropyl myristatc (IPM) 0.028 ± 0.002 0.0051 5.4 ± 0.39 
Octanol (Oct) 0.44 ± 0.014 0.60 0.73 ± 0.023 
Oimethylformamide (OMF) 0.025 ± 0.002 62.3 0.00041 ± 0.00003 
Propylene glycol (PG) 0.0016 ± 0.00 16.5 0.000097 ± 0.000061 
Ethylene glycol (EG) 0.0047 ± 0.0013 19.6 0.00024 ± 0.000066 
Formamide (Form) 0.015 ± 0.00 13.7 0.0011 ± 0.00010 
O A/PG (1;1) 0.050 ± 0.012 0.98 0.051 ± 0.012 
OA/PG (1 :3) 0.050 ± 0.002 4.3 0.012 ± 0.00047 
O A/PG (1: 14.5) 0.088 ± 0.005 11. 1 0.0079 ± 0.00045 
OCT/PG (1; 1) 0.53 ± 0.32 3.6 0.15±0.089 
Efudex 5% solution 0.006 ± 0.002 
"For diffusion cell studies, 200 mg 5-FU was used in 5 ml IPM or PG, 800 mg in 5 ml DMF, and 400 m g/5 ml of remaining vehicles. 
'Fluxes arc signifi cantly differen t from each other f1 < 0.05 except IPM vs DMF and OA:PG(I ; 1 vs 1: 3) by two-sample I-test. 
' Permeability coeffi cients arc significantl y different from each other p < 0.05. 
x Intercept 
(h) 
14.2 
3.2 
2.3 
0.0 
0.1 
1.1 
3.8 
2.3 
1.7 
2.3 
0.2 
1.9 
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other. Fo r the mixed vehicles , th ere is no sig ni fica nt difference 
in the Auxes of5- FU from 1 :1 or 1:3 mixtures of o leic acid / propylene 
glyco l but the remainder are different from each o ther. Thus, the 
Au x of5-F U from vehi cles in thi s stud y is no t therm odyn ami ca ll y 
contro lled [1 0]. 
T he ph ys ica l properties of the vehicles, m o le fraction so lubil-
ities of 5-FU in vehicles, and calculatt:d PC arc slimmari zt:d in 
Tab le III. Based o n the m o le fra ction so lubiliti es of 5-FU in the 
vehicl es, the peak solubility of 5-FU wou ld bc in a vehi cle ex-
hibitin g a 0, betwt:en 14.8-16.1 (cal/cm ' )! if dimeth ylforlll31llid e 
is excl uded 11 31· T ht: calculated so lu bili ty paraJlleter (0) for 5-FU 
o f 15 (ca l/cm 3)! (Ta ble IV) fits well in this range . The log PC 
was calculated from Eq. 3 in Table I, using the 0" for vehicles 
obtained from the lite rature [3 1 and 8 for 5-FU of 15 (ca l/cmJ)! . 
A so lubility paramcter of 1 0 (cal/cIll J)! was ust:d for the skin 12]. 
and the skin thi ckness was considcred to be co nstant w ithin the 
ran ge of bio logic variabi li ty . These log theoretica l PC va lues are 
shown in T able II I. 
Figure '1 sho ws the plot of th c log of th e t:xperimcntal permc-
abilit y coeffi cients (Kp) vs th e solubilit y parameters of the single 
component vehicles. In thc same fl g urc th e log ca lculated PC for 
the sa nK vehi cles arc plotted aga inst the so lubili ty parameters. If 
the ass umptio n made that the vehicles are not ca usi ng any changes 
in the diffusion coeffici ent is appli ca ble [14, 15]. and if the log PC 
va lues derived from reg ul ar so luti on th eory realistica ll y describe 
the partitionin g proccss in th is diffusion cell system, then the 
difference between each of the log calcul ated PC and the log 
experim ental Kp shou ld be a constant that co rrcsponds to C = 
D/hs in Eq. 4 in Table l. The average difference between the log 
calculated PC and log experimenta l Kp fo r 5-FU in oleic acid , 
dimethy lformamidc, propylene g lycol, eth ylene glycol, and 
forl11amide is 2.454 ± 0.24, w hich wou ld g ive a va lue for C = 
2.88 X IO - J cm / h . Usin g this va lue for the constant, and assulll-
ing that the stratum co rneum thickness provides the main barrier 
to penetratio n by polar solutes and that this thickness (hs) for 
hairl ess m o use skin is about 0.0009 Clll [16]. then the diffusion 
coefficient (D) for 5-FU throu gh skin would be about 7.2 X 
10- 10 CI112/S. This va lue is in the expected range for the diffusion 
coe ffi cient for a Illo lecu le such as 5-FU [171 . 
The va lue for the constant noted above excluded the va lues for 
the log theo retica l PC minus log experimental Kp for isop ro p yl 
Table Ill. Physi cal Properties o f Vehicles and Calculated 
Partition Coeffi cients of 5-Fluorouraci l in Vehicles 
Mole 
Solubility Fraction 
Pararnctcr" Solu bi lity/' Theoretical' 
Vehicles 15,. (cal/cm3)1 X; V(n) log pc;,.,,(n) 
O leic acid (OA) 7.6 1. 8 X 10 - 3 1.35 
Isopropyl myriseaec 8.5 0.0013 x 10- 3 0.78 
(I PM) 
Oceanol (Oct) 10.3 0.73 x 10 - 3 - 0. 13 
Dimcthylformamide 12. 1 70.0 x 10- 3 -0.75 
(DMF) 
Propy lene glycol 14.8 6.1 x lO - J - 1.1 3 
(pG) 
Ethylenc glycol 16.1 8.5 x 10- 3 - 1.08 
(EG) 
Formal1lidc (Form) 17.9 4.6 x 10 - 3 -0.75 
OA/ pG( I : I) 9.3" 1. 5 x 10 - 3 0.52 
OA/PG(1 :3) 10.6" 4.5 x 10 - 3 0.27 
OA/PG(I : 14. 5) 13.5'/ 7.5 x 10 - 3 -0.98 
Oct/ PG(1 : 1) 11.7'/ 3.2 X 10 - 3 -0.65 
' From 13 1, solubi lity parameter of vehicle = Ii •. 
'Calculated from m g icm ' solubility in Table 11 and M , and density of vehicle. 
Mole fraction so lu bility of 5-Auorouraeil (i) in a vehi cle I v(n) I = x,,·(nl. 
("Partition cocrticicllt for distriburion of 5-Auo ro urncil between sk ill and vehicle is 
PCI~,YllI) 
'Ca lculated using eq uation described in text 14. 10 1 
THEOll ETIC AL PART ITION COEFFIC I ENTS FOR 5-FU 149 
Table IV. Gro up Contribution M cthod for Calcu lating 
Mo lar Volume and Solubility Paramcter (0) of 
5-Fluo ro uracil [3] 
Atom 
or Group 
Ring closure 
Double bond 
CH= 
C= 
F (attached co C 
atom wi th 
double bond) 
C=O 
NH 
Number of 
Groups 
2 
2 
Energy 
of Vaporiza tion 
(Il E, cal/ mol) 
250 
400 
1030 
1030 
800 
(1000 X 0.8) 
8300 
4000 
lllE = 158 10 
Molar Volum c 
(ll V, cnl"'/ lllo l) 
16. 
-2.2 
13.5 
- 5.5 
18.0 
21.6 
9.0 
_Il V 70.4 
Il = (HE/2AV) = ( 158 10170.4)1 = 15(ea l/em 3)1 
m y ristate and octano!' Prcv io us studies of the delivery of the-
ophylline [11 o r 6-merca p to purinc (unpublished) from isopropyl 
myristate and octa no l have shown that these vehicles, having 
solubility parameters close to the valuc of 10 (cal/cm 3)! for (por-
cine) skin [2]. appear to ha ve a destructive effect on the barrier 
fUllct io n of the skin and thus their values for Aux and permeability 
coefficient do no t tend to fit the predicted rclatio nship . The bro-
ken linc in Fig 1 represents the log theo retica l Kp va lues ca lculated 
from the log theoretical PC minus 2.454. The log expe rim ental 
Kp va lues for the sin g le component vehicles, other than isopropy l 
m yrista te and octanol, approx imate this theoretica l curve. 
Two two- component vchicle sys tcms werc investiga ted in the 
diffusio n cell studies to determ ine whether the relationshi p be-
tween theoretical PC and permeabili ty coefficient would apply 
in this se ttin g. Of particul ar interes t to us was the effect of mi xed 
vehicles usin g the lipid . o leic acid . mi xed with the polar so lvent, 
+2 
+1 
o 
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Figure 1. 5-Fluorouracil in single vehicles. Plot of the log of the theo-
retical partition coeffi cients (solid iiI/ C) and permeability coefficicnts (brokel/ 
lil/ l') vs solubility parameters of the vehicles. Ex perimental va lues for log 
Kp are shown as indi vidual opel/ (iI·ell's. OA = oleic acid ; [PM = isopropyl 
myristate; OCT = octanol; DMF = dimcth ylforll1amidc; PC = pro-
pylenc glycol; EC = ethylene glycol; FORM = formamide. 
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propylene g lycol, since studies by Cooper had suggcsted such a 
mi xcd systcm cou ld enh ance skin perm eability for lipophilic mol-
ccules such as sa licy lic acid [1 8] and po lar moleculcs such as acy-
clovir \1 9]. Sincc the highes t flu x of 5-FU from any single com-
ponent vchicle was rca lizcd from octanol, the effect of a mixture 
of octano l and propylenc glycol (1 :1) on flu x of 5-FU was also 
cxa mincd . Thc data for th e cxperim ental flu x, so lubility an d 
pcrmcability cocfficicnt for cach of these mixed vehicles arc in-
cluded in Tablc II , and thc calculatcd solubility parameters and 
log partition coefficients are shown in Table III. It is notable that 
the addition of oleic acid to propylcne g lycol in thc vehiclc does 
modcrately incrcase the flu x of5-FU through sk in in the diffu sion 
cell system compared with propylcnc glycol alonc but not to o lcic 
acid alone. This incrcased flu x from thc 2-componcnt vehiclc is 
associatcd w ith a decrcascd solubility of5-FU in the mi xed vehicle 
as morc oleic acid is addcd compared with 5-FU in propylene 
g lycol. T hc flux of 5-FU from oleic acid :propylenc glyco l (1: 
14.5),0 = 13.5 (cal/cm3)!, and from octanol:propylcnc g lycol (1: 
I ), 0 = 11.7 (cal/cm3)! was mu ch g reater than the flu x of 5-FU 
from a singlc component vchicle at a similar 0 va lue ldimcthyl-
formam ide, 0 = 12. 1 (ca l/cm3)!]. This difference may be du c to 
the vcry hi gh solubility of 5-FU in the dim ethylformamide . On 
the othcr hand , there was a clea r in vcrse relation between Kp and 
solubi li ty w hich numcrous investiga tors havc shown before [1 ,20]. 
D ISCUSSION 
Previous studies by Sloan ct al [1,11] on thcophyllinc and sa licy lic 
acid had show n that from knowledge of thc solubility parameters 
of vchicl es, drug, and skin , thcoretica l PC of drug betwcen vchicle 
and skin could bc calculated and that fro m these PC va lues it was 
possible to predi ct va lues fo r perm ea bility coefficients of the dru g. 
U sing this pred icted Kp valuc and the solub ility of the drug in 
the vchicle, the flu x of the drug through thc skin also could be 
pred ictcd. T hc goal in thc current study was to detcrmine, using 
this sa mc theorctical relationship, w hcther one could predict w hich 
vchicle wOLtld givc maxim um delivery of 5-FU . 
Fo r single-component vchicles exhibiting a solubili ty parameter 
rangc of 7.6-18 (cal/cm3)!, the theoreti ca l Kp valucs for 5-FU 
obtaincd from Eq. 1 generally correlate wcll with thc cxpcri-
mental Kp valucs obta ined from diffusion cell expcrim ents and 
the dctcrmined solu bi lities. Thc cxccption to this is for those 
vehiclcs, isopropyl myristate (0 = 8.5) and octanol [0 = 10.3, 
(cal/cm3)!]. which have solubility parametcrs similar to that of 
skin (21. For these two vchicles, th e cxperimental flu x and Kp 
wcre mu ch highcr than would bc expcctcd. This is similar to 
w hat is secn for the diffusion of theophylline (1] and 6-merca p-
topurine but not sa licylic acid [11] from th csc vehiclcs . T his result 
has also been secn previously for thc effect of octano l on butyric 
acid flu x (21]. It is thou ght th at this enhanced flu x is due to 
irrcvcrsible damage by isopropyl m yrista te and octanol to the 
lipids in the stratum corneum , thus altering the barrier function 
for polar drugs (22]. A scannin g electron mi croscopic study of 
thc treatcd stratum corneum may help clarify the destructive cffect 
of such vehicles, and this work is planned. A sccond application 
of a po lar drug such as theoph ylline to skin in diffu sion cells afte r 
th ey had bccn prctreated w ith 5-FU , 6-mcrcaptopurine (unpub-
lished data) theophylline [1] , o r salicylic acid [11] in isop ropyl 
m yristate or octanol, or thesc two vehicles alone, dcmonstrates 
much higher flu x of theoph ylline than would be expected , also 
supporti ng the idea that isopropyl myristate and octano l arc per-
mancntly altering the permeability barrier of the skin toward polar 
dru gs. It has been suggested by Sloan et al [11] that sa licyli c acid 
behaves like a nonpolar drug in these (octano l, isopropy l m y-
ristate, o lcic acid) lipid-like vehiclcs. If the lipid vchicles damage 
th e barricr to absorption of polar dru gs by leaching the lipid part 
of the barrier leaving a more polar barrier, then salicylic acid 
absorption would no t be enhanced and in fac t should be retarded 
(11 ]. 
As the solubility parameter of the vehicle approaches that of 
5-FU (0 = 15 (ca l/cm3)!, Table IV), the solubili ty of5-FU in that 
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vehicle is increased so that flu x and subsequcntl y the permcability 
coeffi cicnt (Kp) decrease to a minimum (Table II ). M aximum 
solubility for 5-FU was actuall y scen with d imethylfo rmamidc 
lov = 12. 1 (ca l/cm3)!] but dimethyl formam ide is such a good 
solvent bccause it forms strong so lvates and complcxes wi th sol-
utes th at it does not fit the relationship between solubility and 
solubili ty para m etcrs of the vehicles [13] . 
The axis of the parabola obtained by plo ttin g the log theorctical 
PC of 5-FU in the vehicles vs solubility param eter (Fig 1) is OJ 
= 15(cal/cm3)! sincc this was the OJ used for 5- FU . Thc axis for 
the expcri mental Kp is also approximately 15 (ca l/cm 3)!, sug-
gestin g that this calculatcd OJ for 5-FU approaches a reasonable 
valuc. T his findin g of incrcased solubili ty and decrcased flu x of 
a drug w hen its solubility parameter is close to that of the vehicle 
has been seen previously by our group and others \1 ,11,23]. It 
suggests that the solubility parameters of drug and vehicle must 
be suffic ientl y di ffe rent to allow ready releasc of dru g from the 
vchiclc fo r effici ent percutaneo us penetration [6]. These findings 
also show the utility of using solubility param etcrs in describing 
the partitioning process of 5- FU fro m vchicl es wi th widely dif-
ferent properties . T he fai rly constant relationship between the 
th eoretical PC calcu latcd from act ivity coefficients and the ex-
perimental permeability coeffici ents also suggests that ass ump-
tions made about thc diffusion coeffi cient are justified, except 
when the so lubili ty parameter of the vehicle is close to that of 
skin . 
There are other theo rctical methods that have bcen put forth 
to predict skin permeability. Osborne [24] recentl y reviewcd 4 
such modcls and comparcd their predictive value w ith expcri-
mental flux va lucs for 10 different drugs. Osborne fo und that 
models using wa ter solubility, molecular weight, and PC data 
put forth by Bcrner and Coopcr (25]. Michaels and colleagues 
[26], and Albery and Hadgraft [27,28] werc all useful in predicting 
flu x through thc skin bar rier, but all bad some limitati ons. D ugard 
and Scott [20] recently described a m eth od of predicting percu-
taneous absorption rates in various vehicles based on mo le fraction 
solubili ty of the penetrant in a g ivcn vehicle. Generall y, our results 
fo llow the sa me trend as Dugard and Scott put forth with perme-
ability coefficient being in versely proportional to the solu bility 
of 5-FU in the vehicle; the exceptions being dim ethylformamide 
(in w hich 5-FU is more soluble than ex pected based on its sol-
ubility pa rameter) , and isopropyl myristate and octanol (from 
which 5-FU ex hibits higher than expected Kp va lues). 
In summary, solubility parameters of a drug such as 5-FU and 
vehicle can be used to calculatc a theoretical PC which, in turn , 
can bc used to estimate a theoretica l permeability coeffic ient. With 
this thcoretica l permea bility coefficient and the experimentally 
determined solu bi lity of 5-FU in a g iven vehicle, a rcasonable 
determination of flu x can be calculated . This computationalmcthod 
fo r predi cting skin perm eability compares favorabl y, in our ex-
perience, with other methods recently revicwcd [20,24]. and may 
offer thc potential advantage of decreasing the need for deter-
mining cxperim ental PC o r for in vitro anima l skin experim cnts 
to detcrmine flu x ofinvcst igational drugs through sk in . T hc high-
cst flu x of 5-FU from any vehicle was realized with octanol. 
Although octanol has been found to compro mise the skin 's barrier 
to pcrmeation \1], othcr vehicles ex hibiting similar physical prop-
erties (i.e. , solubility parameters close to th at of sk in) may be 
fo und that arc not as damagin g as octano l ye t rcta in the abi lity 
to enhance penetration like octano!' 
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